# 2026-09023: FDA Unveils Rules for Custom Orthopedic Implants Tailored to Patients

2026-09023, Patient-Matched Guides for Orthopedic Implants; Guidance for Industry and Food and Drug Administration Staff; Availability, is a Federal Register notice from Health and Human Services Department, Food and Drug Administration published 2026-05-07, effective 2026-05-07; PRIA reads it as touching household money (as of 2026-06-08).

- Canonical: https://policyrisk.com/federal-register/2026-09023
- As of: 2026-06-08
- Plain-text twin of the page above; the HTML and this file carry the same facts.

## Facts
- Document number: 2026-09023
- Title: Patient-Matched Guides for Orthopedic Implants; Guidance for Industry and Food and Drug Administration Staff; Availability
- Type: Notice
- Agencies: Health and Human Services Department; Food and Drug Administration
- Citation: 91 FR 24876
- Published: 2026-05-07
- Effective: 2026-05-07
- Comments close: not stated
- Significant: no
- Touches household money: yes
- Regulation identifier numbers: none
- Last updated: 2026-06-08

## In one line

FDA Unveils Rules for Custom Orthopedic Implants Tailored to Patients

## Summary

The FDA just released new guidance to help companies make and submit patient-matched guides for orthopedic implants. This means clearer rules and smoother reviews for devices tailored to each patient’s body. Manufacturers should start following these tips now to speed up approvals and avoid costly delays.

## Abstract

The Food and Drug Administration (FDA or Agency) is announcing the availability of a final guidance titled "Patient-Matched Guides for Orthopedic Implants." This guidance document provides recommendations regarding information that should be included in regulatory submissions for patient-matched guides for orthopedic implants. This guidance also provides recommendations that manufacturers should consider when developing their design process for these device types. This guidance is intended to promote clarity and transparency as to expectations regarding submission recommendations for orthopedic patient-matched guides. Following such recommendations may increase efficiency and consistency in review.

## Effects PRIA read

- Clear submission tips to speed reviews: benefit, medium. The FDA released final guidance titled "Patient-Matched Guides for Orthopedic Implants" on May 7, 2026 that gives companies recommendations on what information to include in regulatory submissions and on design practices. If manufacturers follow these recommendations, the FDA says it may increase e…
- Clarified triggers for new 510(k) submissions: cost, medium. The guidance clarifies certain design modifications that the FDA would consider likely to require submission of a new 510(k). If a manufacturer makes those kinds of modifications, they may need to submit a new 510(k), which can add regulatory steps and costs.
- No new paperwork collections required: benefit, low. The guidance states it contains no new collection of information under the Paperwork Reduction Act and instead refers to previously approved FDA information collections (for example, 21 CFR parts and OMB control numbers listed in the notice). This means the guidance does not add new paperwork requi…
- Guidance is non-binding; alternatives allowed: benefit, low. The FDA says the guidance represents its current thinking and is not binding on FDA or the public; manufacturers may use alternative approaches if those approaches satisfy applicable statutes and regulations. This preserves flexibility for companies in how they meet regulatory requirements.

## Related documents

- [2026-20848](https://policyrisk.com/federal-register/2026-20848): Use of Salt Substitutes To Reduce the Sodium Content in Standardized Foods, 2026-10-13
- [2026-16296](https://policyrisk.com/federal-register/2026-16296): Substances Generally Recognized as Safe, 2026-08-11
- [2026-14073](https://policyrisk.com/federal-register/2026-14073): Drug Establishment Registration and Drug Listing Requirements for Establishments Engaged in Distributed Manufacturing and Certain Foreign E…, 2026-07-13
- [2026-13047](https://policyrisk.com/federal-register/2026-13047): Establishment Registration and Product Listing for Tobacco Products, 2026-06-29
- [2025-04978](https://policyrisk.com/federal-register/2025-04978): Nonprescription Drug Product With an Additional Condition for Nonprescription Use, 2025-03-25
- [2025-01840](https://policyrisk.com/federal-register/2025-01840): Nonprescription Drug Product With an Additional Condition for Nonprescription Use, 2025-01-27

## Sources
- [2026-09023 on federalregister.gov](https://www.federalregister.gov/documents/2026/05/07/2026-09023/patient-matched-guides-for-orthopedic-implants-guidance-for-industry-and-food-and-drug)
- [2026-09023 as published (PDF)](https://www.govinfo.gov/content/pkg/FR-2026-05-07/pdf/2026-09023.pdf)

## Related
- [Previous: 2026-09022, Colorado River Basin Salinity Control Advisory Council Notice of Public Meeting](https://policyrisk.com/federal-register/2026-09022)
- [Next: 2026-09025, Accreditation and Approval of SGS North America, Inc. (Texas City, TX) as a Com…](https://policyrisk.com/federal-register/2026-09025)
- [All Federal Register documents](https://policyrisk.com/federal-register)

Source: PRIA, https://policyrisk.com/federal-register/2026-09023 (as of 2026-06-08).
